1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPA1L2 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA PSD CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA RNF38 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA FZD3 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA C11orf68 CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA ZNF184 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA CNOT6 CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA RBBP4 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA NTN3 CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA PANK1 CTRPv2 pan-cancer AAC 0.18 4e-07
Download CSV